Market Cap ₹305 Cr.
Stock P/E 11.4
P/B 1.2
Current Price ₹143
Book Value ₹ 114.9
Face Value 10
52W High ₹148
Dividend Yield 0%
52W Low ₹ 81
Gillanders Arbuthnot & Company Ltd is a diversified Indian conglomerate with a rich history and a strong presence in various industries. The company has successfully navigated through economic landscapes, evolving to become a prominent player in sectors such as tea, engineering, and infrastructure. Known for its commitment to quality, sustainability, and innovation, Gillanders Arbuthnot has established itself as a trusted name in the business world. With a focus on responsible business practices, the company continues to adapt and thrive in the ever-changing market, contributing significantly to India's economic growth while maintaining its core values of integrity and excellence.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 103 | 77 | 88 | 105 | 101 | 69 | 85 | 127 | 128 | 104 |
| Other Income | 6 | 8 | 5 | 2 | 8 | -1 | 2 | 4 | 1 | 4 |
| Total Income | 109 | 85 | 92 | 107 | 110 | 68 | 87 | 130 | 129 | 108 |
| Total Expenditure | 102 | 94 | 90 | 96 | 126 | 84 | 90 | 101 | 120 | 106 |
| Operating Profit | 7 | -9 | 2 | 11 | -16 | -17 | -4 | 29 | 9 | 2 |
| Interest | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | -0 |
| Profit Before Tax | 0 | -16 | -5 | 4 | -23 | -22 | -10 | 23 | 15 | -4 |
| Provision for Tax | -0 | -5 | 0 | 1 | -1 | 2 | 0 | 2 | 2 | -6 |
| Profit After Tax | 1 | -11 | -5 | 4 | -22 | -25 | -10 | 21 | 13 | 2 |
| Adjustments | -0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -11 | -5 | 4 | -22 | -25 | -10 | 21 | 13 | 2 |
| Adjusted Earnings Per Share | 0.3 | -5.1 | -2.5 | 1.7 | -10.5 | -11.6 | -4.6 | 10.1 | 6.1 | 1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 875 | 820 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 | 444 |
| Other Income | 9 | 11 | 12 | 21 | 12 | 17 | 9 | 17 | 20 | 14 | 11 | 11 |
| Total Income | 884 | 830 | 693 | 685 | 763 | 677 | 440 | 424 | 469 | 377 | 454 | 454 |
| Total Expenditure | 833 | 813 | 658 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 | 417 |
| Operating Profit | 51 | 17 | 35 | 70 | 77 | 45 | 40 | 47 | 32 | -20 | 36 | 36 |
| Interest | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 | 12 |
| Depreciation | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 22 | 0 | 0 | 10 | -2 | 0 | 11 | 0 | 12 | 12 |
| Profit Before Tax | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 | 24 |
| Provision for Tax | -3 | 2 | 1 | 5 | 6 | 3 | 0 | -5 | -3 | 3 | -2 | -2 |
| Profit After Tax | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 26 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 26 |
| Adjusted Earnings Per Share | -4.2 | -25.9 | -8.8 | -4 | 0.2 | -7.1 | -7.3 | 7.7 | 6.9 | -22.8 | 12.5 | 12.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 22% | 3% | -8% | -7% |
| Operating Profit CAGR | 0% | -9% | -4% | -3% |
| PAT CAGR | 0% | 19% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 71% | 35% | 37% | 11% |
| ROE Average | 12% | -1% | -0% | -5% |
| ROCE Average | 10% | 3% | 4% | 5% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 290 | 178 | 284 | 292 | 289 | 276 | 253 | 270 | 277 | 217 | 245 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 160 | 216 | 196 | 166 | 151 | 113 | 77 | 69 | 38 | 30 | 26 |
| Other Non-Current Liabilities | 61 | 24 | 22 | 18 | 27 | 29 | 24 | 19 | 15 | 42 | 32 |
| Total Current Liabilities | 474 | 447 | 444 | 476 | 468 | 449 | 281 | 249 | 228 | 197 | 219 |
| Total Liabilities | 985 | 865 | 945 | 952 | 935 | 867 | 634 | 607 | 558 | 486 | 522 |
| Fixed Assets | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 |
| Other Non-Current Assets | 134 | 101 | 61 | 78 | 73 | 53 | 38 | 38 | 30 | 35 | 55 |
| Total Current Assets | 431 | 454 | 443 | 442 | 435 | 393 | 281 | 258 | 230 | 189 | 211 |
| Total Assets | 985 | 865 | 945 | 952 | 935 | 867 | 634 | 607 | 558 | 486 | 522 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 8 | 21 | 23 | 22 | 2 | 3 | 4 | 2 | 1 | 3 | 2 |
| Cash Flow from Operating Activities | 38 | 40 | 47 | 69 | 102 | 73 | 68 | 69 | 48 | 33 | 8 |
| Cash Flow from Investing Activities | -44 | -8 | 41 | -14 | -18 | 1 | 108 | -2 | 11 | -3 | -7 |
| Cash Flow from Financing Activities | 18 | -30 | -83 | -74 | -82 | -73 | -178 | -68 | -57 | -30 | -3 |
| Net Cash Inflow / Outflow | 13 | 3 | 5 | -20 | 1 | 1 | -2 | -1 | 2 | -0 | -2 |
| Closing Cash & Cash Equivalent | 21 | 24 | 28 | 2 | 3 | 4 | 2 | 1 | 3 | 2 | 1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -4.16 | -25.94 | -8.83 | -4.01 | 0.15 | -7.13 | -7.32 | 7.66 | 6.95 | -22.78 | 12.52 |
| CEPS(Rs) | 5.71 | -17.07 | 1.51 | 7.34 | 9.63 | 2.08 | 0.19 | 13.49 | 12.55 | -17.27 | 17.61 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 97.94 | 82.49 | 132.98 | 136.8 | 135.46 | 129.3 | 118.37 | 126.44 | 129.69 | 101.89 | 114.88 |
| Core EBITDA Margin(%) | 4.79 | 0.8 | 3.44 | 7.47 | 8.7 | 4.31 | 7.09 | 7.31 | 2.65 | -9.21 | 5.78 |
| EBIT Margin(%) | 3.38 | -0.2 | 5.19 | 6.92 | 7.62 | 5.34 | 5.02 | 8.53 | 6.7 | -8.7 | 8.4 |
| Pre Tax Margin(%) | -1.38 | -6.42 | -2.66 | -0.61 | 0.9 | -1.89 | -3.54 | 2.82 | 2.7 | -12.61 | 5.62 |
| PAT Margin (%) | -1 | -6.7 | -2.77 | -1.29 | 0.04 | -2.31 | -3.63 | 4.01 | 3.29 | -13.32 | 6.01 |
| Cash Profit Margin (%) | 1.38 | -4.41 | 0.47 | 2.36 | 2.74 | 0.67 | 0.1 | 7.07 | 5.94 | -10.1 | 8.46 |
| ROA(%) | -1.4 | -5.98 | -2.08 | -0.9 | 0.03 | -1.69 | -2.08 | 2.63 | 2.54 | -9.31 | 5.3 |
| ROE(%) | -5.44 | -28.75 | -8.2 | -2.98 | 0.11 | -5.39 | -5.91 | 6.25 | 5.42 | -19.68 | 11.55 |
| ROCE(%) | 6.84 | -0.25 | 5.1 | 6.35 | 8.19 | 5.33 | 3.86 | 7.46 | 6.92 | -8.27 | 10.22 |
| Receivable days | 32.63 | 57.66 | 61.64 | 54.52 | 47.27 | 49.54 | 61.5 | 46.26 | 26.63 | 27.76 | 37.44 |
| Inventory Days | 46.04 | 71.21 | 86.43 | 94.9 | 90.47 | 95.6 | 108.81 | 98.85 | 92.62 | 100.23 | 76.25 |
| Payable days | 52.6 | 89.27 | 138.19 | 168.95 | 159.99 | 174.63 | 234.56 | 217.28 | 157.47 | 162.67 | 124.3 |
| PER(x) | 0 | 0 | 0 | 0 | 322.58 | 0 | 0 | 8.52 | 8.93 | 0 | 7.69 |
| Price/Book(x) | 0.54 | 0.74 | 0.49 | 0.45 | 0.36 | 0.15 | 0.37 | 0.52 | 0.48 | 0.72 | 0.84 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.64 | 0.74 | 0.85 | 0.82 | 0.65 | 0.58 | 0.72 | 0.78 | 0.61 | 0.78 | 0.78 |
| EV/Core EBITDA(x) | 11.07 | 35.15 | 16.36 | 7.79 | 6.29 | 8.41 | 7.82 | 6.74 | 8.67 | -14.15 | 9.48 |
| Net Sales Growth(%) | 151.07 | -6.37 | -16.91 | -2.38 | 12.99 | -12.13 | -34.74 | -5.65 | 10.49 | -19.1 | 21.99 |
| EBIT Growth(%) | 24.6 | -105.64 | 2203.91 | 30 | 24.39 | -38.44 | -38.59 | 60.69 | -13.04 | -205.02 | 217.59 |
| PAT Growth(%) | -178.23 | -523.59 | 65.94 | 54.56 | 103.78 | -4795.96 | -2.66 | 204.58 | -9.29 | -428.03 | 154.96 |
| EPS Growth(%) | -162.28 | -523.6 | 65.94 | 54.56 | 103.78 | -4794.67 | -2.66 | 204.58 | -9.29 | -428.03 | 154.96 |
| Debt/Equity(x) | 2.15 | 2.68 | 1.58 | 1.45 | 1.35 | 1.33 | 0.9 | 0.68 | 0.52 | 0.59 | 0.57 |
| Current Ratio(x) | 0.91 | 1.02 | 1 | 0.93 | 0.93 | 0.88 | 1 | 1.03 | 1.01 | 0.96 | 0.96 |
| Quick Ratio(x) | 0.57 | 0.65 | 0.64 | 0.54 | 0.53 | 0.52 | 0.65 | 0.54 | 0.54 | 0.48 | 0.54 |
| Interest Cover(x) | 0.71 | -0.03 | 0.66 | 0.92 | 1.13 | 0.74 | 0.59 | 1.49 | 1.68 | -2.22 | 3.02 |
| Total Debt/Mcap(x) | 4.04 | 3.65 | 3.24 | 3.22 | 3.74 | 9.04 | 2.44 | 1.32 | 1.09 | 0.83 | 0.68 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.08 | 69.08 | 69.08 | 69.08 | 69.08 | 69.08 | 69.08 | 69.08 | 69.08 | 69.21 |
| FII | 0 | 0 | 0 | 0.01 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.67 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 30.25 | 30.57 | 30.57 | 30.56 | 30.47 | 30.57 | 30.57 | 30.57 | 30.57 | 30.44 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.48 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
